View in EDS HTML Full Text PDF Full Text

Metabolic impact of low dose IL-2 therapy for primary Sjögren's Syndrome in a double-blind, randomized clinical trial.

Saved in:
Bibliographic Details
Title: Metabolic impact of low dose IL-2 therapy for primary Sjögren's Syndrome in a double-blind, randomized clinical trial.
Authors: Feng, Ruiling1 (AUTHOR), Xiao, Xian1 (AUTHOR), Wang, Yifan1 (AUTHOR), Huang, Bo1 (AUTHOR), Chen, Jiali1 (AUTHOR), Cheng, Gong1 (AUTHOR), Jin, Yuebo1 (AUTHOR) xianglifuer@163.com
Source: Clinical Rheumatology. Dec2024, Vol. 43 Issue 12, p3789-3798. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:07703198
DOI:10.1007/s10067-024-07165-2